摘要
前列腺癌是最难治疗的癌症之一,特别是当它变成激素抵抗时,例如去势抵抗性前列腺癌(CRPC)和随后的转移性CRPC。除了前列腺癌的遗传改变之外,表观遗传修饰也在该疾病的发展和肿瘤进展中发挥重要作用。这些包括DNA甲基化,组蛋白修饰和非编码微RNA。 miRNA是一类长度为19-25个核苷酸的小内源性单链非编码RNA,其通常沉默基因表达。考虑到早期癌变过程中表观遗传改变的可逆性,绿茶儿茶素对这些修饰的逆转(校正)可能是癌症化学预防和治疗的有前途的策略。最近的证据表明绿茶儿茶素如表没食子儿茶素没食子酸酯(EGCG)不仅作为表观遗传调节剂,而且还可以修饰miRNA表达及其靶mRNA,一直有助于抑制前列腺癌发生。各种研究还表明,几种绿茶多酚(GTPs)与其他癌症化疗剂发挥协同作用。因此,使用绿茶儿茶素与现有化学治疗剂的适当组合将导致副作用减少而不降低化疗效果。这篇综述将总结最近研究的关键结果,详细描述绿茶儿茶素如EGCG对前列腺癌中表观遗传学改变和miRNA表达的影响。
关键词: 前列腺癌,miRNAs,儿茶素,多酚,表观遗传学改变。
Current Molecular Medicine
Title:Epigenetic Changes Induced by Green Tea Catechins a re Associated with Prostate Cancer
Volume: 17 Issue: 6
关键词: 前列腺癌,miRNAs,儿茶素,多酚,表观遗传学改变。
摘要: Prostate cancer is one of the most difficult cancers to treat especially when it becomes hormone resistant such as castrate resistant prostate cancer (CRPC) and subsequent metastatic CRPC. Apart from the genetic alterations in prostate cancer, epigenetic modifications also play an important role in the development and neoplastic progression of this disease. These include DNA methylation, histone modifications, and non-coding microRNAs. miRNAs are a novel class of small endogenous single-stranded non-coding RNAs of 19-25 nucleotides in length that typically silence gene expression. Considering the reversibility of epigenetic alterations in early carcinogenesis process, reversion (correction) of these modifications by green tea catechins could be a promising strategy for cancer chemoprevention and therapy. Recent evidence suggests that green tea catechins such as epigallocatechin gallate (EGCG) not only act as epigenetic modulators but can also modify miRNA expression and their target mRNAs, consistently contributing to the inhibition of prostate carcinogenesis. Various studies also indicate that several green tea polyphenols (GTPs) exert synergistic effects with other cancer chemotherapeutic agents. Therefore, the use of appropriate combinations of green tea catechins with the existing chemotherapeutics will lead to a reduction in side effects without decreasing the chemotherapeutic effects. This review will summarize the key results from recent studies detailing the effects of green tea catechins such as EGCG on epigenetic alterations and miRNA expression in prostate cancer.
Export Options
About this article
Cite this article as:
Epigenetic Changes Induced by Green Tea Catechins a re Associated with Prostate Cancer, Current Molecular Medicine 2017; 17 (6) . https://dx.doi.org/10.2174/1566524018666171219101937
DOI https://dx.doi.org/10.2174/1566524018666171219101937 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Potential Molecular Targets of Ampelopsin in Prevention and Treatment of Cancers
Anti-Cancer Agents in Medicinal Chemistry Cationic Liposomes as Non-viral Vector for RNA Delivery in Cancer Immunotherapy
Recent Patents on Drug Delivery & Formulation Kisspeptin: A Critical Regulator of Puberty and Reproductive Function
Current Drug Targets Sesterterpenoids with Anticancer Activity
Current Medicinal Chemistry Vitamin D, Sunlight and Cancer Connection
Anti-Cancer Agents in Medicinal Chemistry Epigenetic Effects of Cadmium in Cancer: Focus on Melanoma
Current Genomics Antithrombin, an Important Inhibitor in Blood Clots
Current Topics in Medicinal Chemistry Serpins for Diagnosis and Therapy in Cancer
Cardiovascular & Hematological Disorders-Drug Targets Use of the Semiconductor Nanotechnologies “Quantum Dots” for in vivo Cancer Imaging
Recent Patents on Anti-Cancer Drug Discovery Systemic Delivery of Curcumin: 21st Century Solutions for an Ancient Conundrum
Current Drug Discovery Technologies Reduced NGF Secretion by HT-29 Human Colon Cancer Cells Treated with a GRPR Antagonist
Protein & Peptide Letters An Update on Extemporaneous Preparation of Radiopharmaceuticals Using Freeze-Dried Cold Kits
Mini-Reviews in Medicinal Chemistry Natural and Synthetic Retinoids in Prostate Cancer
Current Pharmaceutical Design Advanced Methods for the Analysis of Testosterone
Current Medicinal Chemistry Prevention and Treatment of Alzheimer Disease and Aging: Antioxidants
Mini-Reviews in Medicinal Chemistry Deregulation of PI3K/Akt/mTOR Signaling Pathways by Isoflavones and its Implication in Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry EDITORIAL [Hot topic: RAS - A Central Feature in Cancer Targeted Therapy (Guest Editor: Balazs Gyorffy)
Current Cancer Drug Targets Subject Index to Volume 4
Current Drug Targets Cellular Senescence as a Target in Cancer Control
Current Cancer Therapy Reviews Melanocortins As Innovative Drugs for Ischemic Diseases and Neurodegenerative Disorders: Established Data and Perspectives
Current Medicinal Chemistry